Association between CYP2D6 Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during Pregnancy

Association between CYP2D6 Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during Pregnancy

Importance: Polymorphic expression of drug metabolizing enzymes affects the metabolism of antidepressants, and thus can contribute to drug response and/or adverse events. Pregnancy itself can affect CYP2D6 activity with profound variations determined by CYP2D6 genotype.Objective: To investigate the...

Full description

Bibliographic Details
Main Authors: Anick Bérard, Andrea Gaedigk, Odile Sheehy, Christina Chambers, Mark Roth, Pina Bozzo, Diana Johnson, Kelly Kao, Sharon Lavigne, Lori Wolfe, Dee Quinn, Kristen Dieter, Jin-Ping Zhao, the OTIS (MotherToBaby) Collaborative Research Committee
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-07-01
Series:Frontiers in Pharmacology
Subjects:
CYP2D6 genotypes
antidepressant discontinuation
dosage modification
maternal depression in pregnancy
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00402/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2017.00402/full

Similar Items